Idera Pharmaceuticals is Drug Discovery in United States that focus on Idera Pharmaceuticals Inc business. Founded in 1989. They cover business area such as Idera Pharmaceuticals Inc, development, commercialization, innovative therapeutic, oncology and rare disease, two distinct proprietary drug-discovery technology platform, toll-like receptor, third-generation antisense technology, synthetic oligonucleotide-base drug candidate.
1989
( 35 years old in 2024 )
Idera Pharmaceuticals Inc
-
505 Eagleview Boulevard
Suite 212
Exton, PA 19341
United States
Private
Idera Pharmaceuticals Incdevelopmentcommercializationinnovative therapeuticoncology and rare diseasetwo distinct proprietary drug-discovery technology platformtoll-like receptorthird-generation antisense technologysynthetic oligonucleotide-base drug candidate
* We use standard office opening hours in near Idera Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Idera Pharmaceuticals is Drug Discovery business from United States that founded in 1989 (35 years old in 2024), Idera Pharmaceuticals business is focusing on Idera Pharmaceuticals Inc.
Idera Pharmaceuticals headquarter office and corporate office address is located in 505 Eagleview Boulevard Suite 212 Exton, PA 19341 United States.
Idera Pharmaceuticals was founded in United States.
In 2024, Idera Pharmaceuticals is currently focus on Idera Pharmaceuticals Inc sector.
Above is snippet of Google Trends for "Idera Pharmaceuticals Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Idera Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
